Product Images Glipizide

This is a description of Glipizide USP tablets, used for treating diabetes, available only on prescription. The usual dosage of the tablets is to be determined according to the package insert. The tablets need to be stored in a controlled room temperature of 20° to 25°C and in a tight, light-resistant container with child-resistant closure. The manufacturer of the tablets is ANI Pharmaceuticals Canada, Inc., while ANI Pharmaceuticals, Inc. distributes them. The product contains 5mg of glipizide USP per tablet. This text does not give any information about the side-effects and contraindications of the medicine.*

This is a medication information sheet for Glipizide USP tablets with NDC 62559-316-10. Each tablet contains an unspecified amount of Glipizide USP. Recommended dosage information can be found in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F) in controlled room temperature. The medication must be kept out of the reach of children and dispensed in a tight, light-resistant container with a child-resistant closure. The manufacturer of the medication is AANI Pharmaceuticals Canada, Inc. and it is distributed by ANI Pharmaceuticals, Inc. There is no information in the text about the medication's indications or contraindications.*